Skip to main content
. 2024 Oct 29;10(21):e39939. doi: 10.1016/j.heliyon.2024.e39939

Fig. 8.

Fig. 8

Docking poses of Tanshinone IIA, Salvianolic acid B, Salvianolic acid A, and Resibufogenin with three core targets. (A) Bax-Tanshinone IIA, Bax-Salvianolic acid A, Bax-Salvianolic acid B, and Bax-Resibufogenin. (B) ERK1-Tanshinone IIA, ERK1-Salvianolic acid A, ERK1-Salvianolic acid B, and ERK1-Resibufogenin. (C) ERK2-Tanshinone IIA, ERK2-Salvianolic acid A, ERK2-Salvianolic acid B, and ERK2-Resibufogenin.